InflaRx (IFRX) Stock: Buy, Sell, or Hold?
IFRX - InflaRx N.V. Common Stock
$1.56
0.03 (1.96%)
▲
5d:
+18.18%
30d:
-19.17%
90d:
-8.24%
BUY
HIGH Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 09, 2026
16d
Get Alerted When IFRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IFRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: IFRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: IFRX is currently trading at $1.56, which is considered slightly low relative to its 30-day fair value range of $1.50 to $1.98.
Technical Outlook: Technically, IFRX is showing sideways momentum. Immediate support is located at $1.28, while resistance sits at $1.64.
Market Sentiment: IFRX scores 90/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.65 (+400.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IFRX is showing sideways momentum. Immediate support is located at $1.28, while resistance sits at $1.64.
Market Sentiment: IFRX scores 90/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.65 (+400.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.50 -
$1.98
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (90/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 400.0% below Wall St target ($7.65)
- BULLISH: Bottoming setup score 90/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$1.50 -
$1.98
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.29
Resistance Level
$1.64
Current Trend
Sideways
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.42
Wall Street Target
$7.65
(+400.0%)
Revenue Growth (YoY)
-80.8%
Share & Embed Analysis
Last updated: October 23, 2026 4:57 PM ET
Data refreshes hourly during market hours. Next update: 5:57 PM
Data refreshes hourly during market hours. Next update: 5:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IFRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1153 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 49 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 63 BUY |
|
CLYM
Climb Bio Inc |
STRONG BUY
15 analysts |
$28 | 63 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 52 HOLD |
